Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Joana Sederias | Researchclopedia

Back to researchers

Joana Sederias

Queen's University

16

Works

796

Citations

9

h-index

9

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Occupational and environmental lung diseases Renal cell carcinoma treatment

Affiliations

Queen's University2009–2024

Princess Margaret Cancer Centre2011–2011

Top Works

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Amit M. Oza,Laurie Elit,et al.

2011335 citations

Pleural and Pulmonary Diseases

Glioma Diagnosis and Treatment

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184

Helen Mackay,Anna V. Tinker,et al.

2009118 citations

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

Quincy S. Chu,Federica Perrone,et al.

202392 citations

Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy

Penelope A. Bradbury,Donald G. Morris,et al.

201855 citations

The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group

Matthew D. Seftel,John Kuruvilla,et al.

201648 citations

A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191

Annette E. Hay,Alli Murugesan,et al.

201537 citations

A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study

Sarah Lapointe,Warren Mason,et al.

201937 citations

IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial.

Quincy S. Chu,Maria Carmela Piccirillo,et al.

202332 citations

Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)

Maria Carmela Piccirillo,Quincy S. Chu,et al.

202322 citations